FOL100
/ Follicle Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 07, 2024
Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
(clinicaltrials.gov)
- P1 | N=90 | Recruiting | Sponsor: Follicle Pharma Ltd | N=66 ➔ 90
Enrollment change • Alopecia • Dermatology • Immunology
November 10, 2022
Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
(clinicaltrials.gov)
- P1 | N=66 | Recruiting | Sponsor: Follicle Pharma Ltd
New P1 trial • Alopecia
1 to 2
Of
2
Go to page
1